It's Not Too Late for Investors to Start Buying GILD Stock

Published on September 16, 2022

Biopharmaceutical giant Gilead Sciences (GILD) has delivered solid segmental sales growth in the last reported quarter. In addition, the company’s various research breakthroughs and drug approvals should further bolster its...

Continue reading on website
Other news

5 Reasons Why Entrepreneurs Should Be Using No Code

September 16, 2022
Today, no-code is dominated by early-stage entrepreneurs to build their MVP or side hustle. But no-code can be used for so much more. It's time for enterprises to become more efficient, innovative and productive.

How to Create a More Productive Culture in Your Business

September 16, 2022
The workplace culture of your business is crucial to your success. Never has that been more important than now, as companies compete for scarce talent reshaped by the pandemic. As...